Filing Details

Accession Number:
0000950170-24-087862
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-07-30 16:15:03
Reporting Period:
2024-07-26
Accepted Time:
2024-07-30 16:15:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1819133 Tango Therapeutics Inc. TNGX () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1688325 Trv Gp Iv, Llc 201 Brookline Ave, Suite 1401
Boston MA 02215
No No No No
1688326 Third Rock Ventures Gp Iv, L.p. 201 Brookline Ave, Suite 1401
Boston MA 02215
No No No No
1688327 Third Rock Ventures Iv, L.p. C/O Third Rock Ventures, Llc
201 Brookline Ave, Suite 1401
Boston MA 02215
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-07-26 50,000 $9.84 17,721,475 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.75 to $10.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).
  2. These shares are directly held by Third Rock Ventures IV, L.P. ("TRV IV"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. ("TRV GP IV"). The general partner of TRV GP IV is TRV GP IV, LLC ("TRV GP IV LLC"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares.